Monoclonal antibody raised in mouse against human p300 (E1A Binding Protein P300) by DNA immunization in which the C-terminal part of the protein was cloned and expressed.
EP300
Reactivity: Human
IHC (p), DB
Host: Rabbit
Polyclonal
RB7876
unconjugated
Application Notes
ChIP/ChIP-seq 5 μg:ChIP
Restrictions
For Research Use only
Format
Liquid
Concentration
0.9 μg/μL
Buffer
PBS, 0.05 % azide, 0.05 % ProClin300
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Target
p300 (EP300)
(E1A Binding Protein P300 (EP300))
Alternative Name
p300
Background
P300 (UniProt/Swiss-Prot entry Q09472) is a histone acetyltransferase that regulates transcription via chromatin remodelling. As such it is important for cell proliferation and differentiation. p300 is able to acetylate all four core histones in nucleosomes. Acetylation of histones is associated with transcriptional activation. p300 also acetylates non-histone proteins such as HDAC1 leading to its inactivation and modulation of transcription. It has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in the p300 gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer.